S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Acceleron PharmaAdaptive BiotechnologiesSpark TherapeuticsChina Biologic ProductsIovance Biotherapeutics
Price Information
Current Price$98.38$43.25$113.57$107.28$30.14
52 Week RangeBuyBuyHoldN/ABuy
Beat the Market™ Rank
Overall Score2.
Analysis Score3.
Community Score3.
Dividend Score0.
Ownership Score4.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyBuyHoldN/ABuy
Consensus Price Target$117.69$49.20$114.50N/A$44.42
% Upside from Price Target19.63% upside13.76% upside0.82% upsideN/A47.37% upside
Trade Information
Market Cap$5.30 billion$5.53 billion$4.37 billion$4.23 billion$3.82 billion
Average Volume1,176,9961,175,303419,933117,7792,002,426
Sales & Book Value
Annual Revenue$73.99 million$85.07 million$64.72 million$503.70 millionN/A
Price / Sales71.5764.5167.598.38N/A
CashflowN/AN/AN/A$4.95 per shareN/A
Price / CashN/AN/AN/A21.69N/A
Book Value$8.47 per share$4.59 per share$13.15 per share$45.09 per share$2.37 per share
Price / Book11.629.428.642.38N/A
Net Income$-124,860,000.00$-68,610,000.00$-78,820,000.00$138.81 million$-197,560,000.00
Trailing P/E RatioN/AN/AN/A27.16N/A
Forward P/E RatioN/AN/AN/A23.95N/A
Net Margins-182.31%-87.47%-358.41%28.80%N/A
Return on Equity (ROE)-30.14%-22.92%-59.10%10.01%-71.12%
Return on Assets (ROA)-27.01%-9.88%-33.13%9.16%-62.87%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.04%N/A0.35%N/A0.01%
Current Ratio15.15%7.50%4.67%10.51%6.48%
Quick Ratio15.15%7.37%4.35%8.86%6.48%
Ownership Information
Institutional Ownership Percentage88.77%76.19%88.37%29.43%95.52%
Insider Ownership Percentage2.50%34.70%6.00%2.73%9.30%
Shares Outstanding53.83 million126.89 million38.52 million39.36 million126.86 million
Next Earnings Date8/3/2020 (Estimated)8/10/2020 (Confirmed)N/A8/3/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.